tiprankstipranks
Trending News
More News >
Minerva Neurosciences (NERV)
NASDAQ:NERV
US Market

Minerva Neurosciences (NERV) Stock Forecast & Price Target

Compare
572 Followers
See the Price Targets and Ratings of:

NERV Financial Forecast

NERV Earnings Forecast

Next quarter’s earnings estimate for NERV is -$0.90 with a range of -$0.90 to -$0.90. The previous quarter’s EPS was -$0.50. NERV beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year NERV has Outperformed its overall industry.
Next quarter’s earnings estimate for NERV is -$0.90 with a range of -$0.90 to -$0.90. The previous quarter’s EPS was -$0.50. NERV beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year NERV has Outperformed its overall industry.

NERV Sales Forecast

Next quarter’s sales forecast for NERV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NERV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year NERV has Preformed in-line its overall industry.
Next quarter’s sales forecast for NERV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NERV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year NERV has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on NERV
Douglas TsaoH.C. Wainwright
H.C. Wainwright
$5
Hold
189.02%
Upside
Reiterated
02/25/25
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on NERV
Douglas TsaoH.C. Wainwright
H.C. Wainwright
$5
Hold
189.02%
Upside
Reiterated
02/25/25
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NERV Analyst Recommendation Trends

Rating
Feb 24
May 24
Aug 24
Nov 24
Feb 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
4
4
4
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
4
3
3
In the current month, NERV has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. NERV average Analyst price target in the past 3 months is 5.00.
Each month's total comprises the sum of three months' worth of ratings.

NERV Stock Forecast FAQ

What is NERV’s average 12-month price target, according to analysts?
Based on analyst ratings, Minerva Neurosciences’s 12-month average price target is 5.00.
    What is NERV’s upside potential, based on the analysts’ average price target?
    Minerva Neurosciences has 189.02% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is NERV a Buy, Sell or Hold?
          Minerva Neurosciences has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Minerva Neurosciences’s price target?
            The average price target for Minerva Neurosciences is 5.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $5.00 ,the lowest forecast is $5.00. The average price target represents 189.02% Increase from the current price of $1.73.
              What do analysts say about Minerva Neurosciences?
              Minerva Neurosciences’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of NERV?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis